Open Label Extension Study to Protocol C2/13/DR-6MP-02 (OLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01433432
Recruitment Status : Withdrawn (Sponsor withdrew support for study due to reorganization and project prioritization)
First Posted : September 14, 2011
Last Update Posted : March 7, 2013
Information provided by (Responsible Party):
Teva GTC

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2012
  Estimated Study Completion Date : August 2012